Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...
Le Lézard13h
Virtual Therapy Market to Reach USD 1.62 Billion by 2031: Growing Demand for Digital Mental Health Solutions | Valuates Reports
The Global Market for Virtual Reality Therapy was valued at USD 1116 Million in the year 2024 and is projected to reach a revised size of USD 1626 Million by 2031, growing at a CAGR of 5.6% during the ...
IBEF20h
Indian E-commerce Industry Analysis
India's Business-to-Business (B2B) online marketplace would be a US$ 200 billion opportunity by 2030. With over 821 million users, India was the second-largest internet market in the world with 117.6 ...
Mint7h
Indian Hume Pipe Company share price
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Indiatimes22h
IPO News
Chandan Healthcare debuted on the NSE SME platform. The company, operating a diagnostic network across Northern India, received a 7x subscription for its IPO. The company derives a significant portion ...